Does TARLATAMAB Cause Disease progression? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Disease progression have been filed in association with TARLATAMAB. This represents 7.6% of all adverse event reports for TARLATAMAB.
11
Reports of Disease progression with TARLATAMAB
7.6%
of all TARLATAMAB reports
6
Deaths
3
Hospitalizations
How Dangerous Is Disease progression From TARLATAMAB?
Of the 11 reports, 6 (54.5%) resulted in death, 3 (27.3%) required hospitalization.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TARLATAMAB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does TARLATAMAB Cause?
Cytokine release syndrome (59)
Death (31)
Immune effector cell-associated neurotoxicity syndrome (30)
Off label use (14)
Small cell lung cancer (10)
Metastases to central nervous system (7)
Therapy partial responder (7)
Pyrexia (6)
Dysgeusia (5)
Hypotension (5)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which TARLATAMAB Alternatives Have Lower Disease progression Risk?
TARLATAMAB vs TARLATAMAB-DLLE
TARLATAMAB vs TASIGNA
TARLATAMAB vs TASIMELTEON
TARLATAMAB vs TAVABOROLE
TARLATAMAB vs TAXOL